A Role for Extracellular Vesicles in Liver Fibrosis  by Karp, Seth J.
EDITORIALA Role for Extracellular Vesicles in Liver Fibrosisxtracellular vesicles comprise exosomes, micro-Evesicles, and apoptotic bodies. Each consists of a
lipid bilayer that encases a variety of contents. Exosomes
are the smallest of the group (40–120 nM) and arise from
the endolysosomal pathway. Microvesicles are middle sized
(50–1000 nM) and occur as a result of outward budding of
the cell surface. Both contain various RNA species and
proteins. Apoptotic bodies are larger (500–2000 nM), form
from budding of the apoptotic cell membrane, and contain
nuclear fragments and cellular organelles.1
Originally described in the early 1980s, extracellular
vesicles were initially thought to be a way for cells to expel
membrane debris.2,3 Over the last few years, research on
extracellular vesicles reveals them to be complex vehicles
for signaling in a wide variety of systems and cell types.
With their heterogeneous contents, extracellular vesicles
seem to be an important mechanism for intercellular
communication. Clear roles have been established in such
diverse processes as tumorigenesis, stem cell maintenance,
immune function, and neurotransmission.1,4–6 To represent
this diverse palette of functions, they have been termed
“signalosomes.”1
In the current issue of Cellular and Molecular Gastroen-
terology and Hepatology, Povero and colleagues7 bring this
powerful new understanding of extracellular vesicles to
investigate the question of stellate cell activation. Although
stellate cell activation has long been known to be a critical
event in the development of ﬁbrosis, the initiating event in
this process is less well understood.
Building on their previous report8 demonstrating that
hepatocytes increase the release of extracellular vesicles in
response to lipotoxic fatty acids, the authors expand these
studies to show that these extracellular vesicles are
internalized by stellate cells, leading to their activation. In
a series of convincing experiments, they demonstrate the
effect is dependent on Vanin 1, a cell-surface protein
thought to be critical for internalization of extracellular
vesicles. Mechanistic studies further elucidate the effect as
a result of the shuttling of peroxisome proliferator-
activated receptor-g (PPAR-g) targeting microRNAs, spe-
ciﬁcally miR-128-3p, a critical modulator of stellate cell
activation.
This work is important for a number of reasons. First, it
establishes extracellular vesicles as a potential modulator
of ﬁbrosis in an increasingly common and devastating hu-
man problem, nonalcoholic fatty liver disease. Further
in vivo studies will be required to verify these ﬁndings in
both animals and humans. Next, it establishes a direct
signaling link from injured or stressed hepatocytes toCellular and Molecular Gastroenterology and Hepatology 2015;1:572–5stellate cells. If conﬁrmed, this would help elucidate the as
yet poorly understood issue of the initial events in stellate
cell activation.
Further, and perhaps most importantly, these studies
suggest targeting extracellular vesicles might have thera-
peutic potential. As understanding of extracellular vesicle
biology improves, methods to inhibit their generation,
modify their contents, or decrease their release or uptake
may ﬁnd a role into the clinic.
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